May 13, 2013
Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health Business

May 8, 2013
Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Latest ASX stock price

All prices delayed at least 20 minutes.
Source: ASX Inc.

Animal Health News Release

Research Shows Promise for Easy, Effective Management of Sow Breeding

07/03/05

BELLEVILLE, ON, March 7, 2005 – Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that recent research using Bioniche products has shown the potential to consistently predict the timing of ovulation in sows.

Dr. Glen Cassar, Assistant Professor at the Ontario Veterinary College at the University of Guelph presented his research, “Towards Timed Single Insemination in Sows”, at the Annual Meeting of the American Association of Swine Veterinarians in Toronto today. Dr. Cassar’s research showed that when Canadian Bioniche products Pregnecol (eCG) and Lutropin-V (pLH) were administered at specific times, ovulation was managed so precisely that just a single, timed, insemination was effective in more than 89% of the sows.

According to Dr. Cassar, “Synchronization of estrus and ovulation with eCG and pLH has the potential to revolutionize sow breeding by artificial insemination.”

“It has been very exciting to watch this research unfold,” said Rick Culbert, President of Bioniche Animal Health Canada. “Most sows currently receive two or more inseminations. A timed single insemination would make it practical to use more premium semen, and realize the benefits of superior genetics.”

Richard Smelski of Ontario Swine Improvement has been working to calculate the potential financial return of this new breeding technology through the use of a computerized pork production model. The calculations were based on a 500 sow farrow to finish herd, using input costs of $10 per sow for Pregnecol and Lutropin, and $7.00 for a single dose of semen. His model demonstrated that with each 5% improvement in farrowing rate, a greater than 2 to 1 return on investment would be realized. An additional reward is the reallocation of labour formerly spent on heat detection and breeding to other objectives such as reducing piglet mortality.

Hog farmers wishing more information on PregnecolLutropin-V (pLH) are advised to contact their veterinarians. Further research to validate these results is underway.

Back

Categories:
All Releases
Archived Releases
Animal Health
Corporate
Financial
Human Health
One Health